Reduced aerobic capacity and growth performance for Gulf of St. Lawrence Acadian redfish ( Sebastes fasciatus ) under chronic hypoxia
ICES Journal of Marine Science · 29.08.2026 · 83 (9)
DOI: 10.1093/icesjms/fsag179 ↗Kurz gefasst
Fachartikel in der Zeitschrift ICES Journal of Marine Science, online erschienen am 22.09.2026. Verfasst von Joëlle J Guitard und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fisheries and Oceans Canada, Natural Sciences and Engineering Research Council of Canada, Fonds de recherche du Québec.
Abstract (Originalsprache)
Ongoing climate change is driving oxygen declines in marine systems primarily due to ocean warming and changes in stratification, reducing both oxygen solubility and vertical mixing. In many regions, including the Gulf of St. Lawrence, Canada, oxygen levels in the deep layer (> 175 m) have reached persistently low levels, resulting in constraints on the physiology of organisms, which in turn affect ecosystem structure. Redfish (Sebastes fasciatus and S. mentella), commercially important species that have recently resurged in the Gulf of St. Lawrence, are now found largely in habitats where oxygen levels range between 25% and 60% dissolved oxygen (DO) saturation. However, little is known about how these conditions shape their physiological performance and energy balance. To address this, we experimentally quantified the effects of chronic exposure (105 days) at eight oxygen levels (25–100% saturation; % sat. hereafter) on food intake, food conversion efficiency (FCE), growth, body condition, aerobic metabolism [standard (SMR) and maximum (MMR) metabolic rates, aerobic scope (AS)], and hypoxia tolerance (O₂crit). Food intake, FCE, and growth rates remained stable above approximately 45% sat., began to decline between 36 and 43% sat., and were significantly reduced below 25–34% sat. Among these traits, FCE showed the strongest response, decreasing in efficiency by approximately 95% at 25% sat. compared with higher oxygen treatments. Change in Fulton’s condition factor (an index of body condition) declined significantly at ca. 32% sat. This pattern corresponds to a linear decrease in MMR, AS and, to a lesser extent, SMR, as DO decreased. These results suggest that redfish maintain sufficient AS down to ca. 45% sat. to sustain normal rates of food consumption and growth. Below this threshold, declining AS is accompanied by reductions in feeding performance and particularly FCE, indicating increasing energetic constraints despite continued survival. According to recent surveys carried out in August 2024, up to 60% of the biomass of S. fasciatus was found at DO levels that start constraining physiological traits according to our results (43% sat.) and further oxygen declines could act as a major limiting factor on their fitness and distribution.
Förderung
- Fisheries and Oceans Canada
- Natural Sciences and Engineering Research Council of Canada
- Fonds de recherche du Québec
- Canada Research Chairs
Zitieren
APA
Guitard, J. J., Chabot, D., Senay, C., Robert, D., & Deslauriers, D. (2026). Reduced aerobic capacity and growth performance for Gulf of St. Lawrence Acadian redfish ( Sebastes fasciatus ) under chronic hypoxia. ICES Journal of Marine Science, 83(9). https://doi.org/10.1093/icesjms/fsag179
Vancouver
Guitard JJ, Chabot D, Senay C, Robert D, Deslauriers D. Reduced aerobic capacity and growth performance for Gulf of St. Lawrence Acadian redfish ( Sebastes fasciatus ) under chronic hypoxia. ICES Journal of Marine Science. 2026;83(9). doi:10.1093/icesjms/fsag179
BibTeX
@article{Guitard2026,
author = {Guitard, Joëlle J and Chabot, Denis and Senay, Caroline and Robert, Dominique and Deslauriers, David},
title = {Reduced aerobic capacity and growth performance for Gulf of St. Lawrence Acadian redfish ( Sebastes fasciatus ) under chronic hypoxia},
journal = {ICES Journal of Marine Science},
year = {2026},
volume = {83},
number = {9},
doi = {10.1093/icesjms/fsag179}
}
EUVIMED